The research is the result of a long project started with the hypothesis that mGlu5 is a mediator of pain sensitization and a viable target for a novel class of analgesics.
Dr. Laura Cavallone’s research on mGlu5 selected as editor’s choice by highly reputable pain journal, PAIN





